Opportunity
Simpler Grants.gov #RFA-JG-26-034
CDC Cooperative Agreement for Public Health Research and Evaluation in Kenya
Buyer
Centers for Disease Control and Prevention - ERA
Posted
May 11, 2026
Respond By
June 23, 2026
Identifier
RFA-JG-26-034
NAICS
541715, 923120
The Centers for Disease Control and Prevention (CDC) Global Health Center/Office of Director is seeking a partner for a major public health research initiative in Kenya. - Government Buyer: - Centers for Disease Control and Prevention (CDC), Global Health Center/Office of Director - Scope of Work: - Cooperative agreement to conduct research, implementation science, and public health evaluations in Kenya - Focus on four priority areas: - Influenza and other respiratory pathogens - Vaccine-preventable diseases - Drug-resistant infections - Global and emerging health threats (including malaria, HIV, tuberculosis, schistosomiasis) - Activities must include research coordination, administration, and compliance with U.S. government financial and ethical standards - Strengthening local research capacity and informing U.S. and global preparedness - Key Partners and Collaboration: - Required collaboration with Kenya Medical Research Institute (KEMRI) and/or Kenya Ministry of Health - Funding and Performance: - Total expected funding: $30 million over five years - Minimum annual award: $6 million - Single award to one recipient - Notable Requirements: - Applicants must address all four priority areas in their application - Demonstrated collaboration with KEMRI and/or Kenya Ministry of Health is mandatory - No specific OEMs or commercial vendors are named, as this is a research and evaluation services opportunity
Description
This notice of funding opportunity (NOFO) supports research, implementation science, and public health evaluations to inform best practices for preventing and responding to infectious disease threats in Kenya, while strengthening local research capacity. The award recipient will conduct research through the Kenya Medical Research Institute (KEMRI) focusing on four priority areas: influenza and other respiratory pathogens, vaccine-preventable diseases, drug-resistant infections, and global and emerging health threats. The recipient will also manage U.S. government-funded public health research, ensuring compliance with financial and ethical standards and enhancing organizational infrastructure. The activities aim to generate evidence to guide U.S. and global preparedness, reduce disease burden in Kenya, and prevent the spread of health threats across borders.